首页|顺铂联合人参皂苷Rh2对4T1乳腺癌荷瘤小鼠的抑瘤及免疫调控机制

顺铂联合人参皂苷Rh2对4T1乳腺癌荷瘤小鼠的抑瘤及免疫调控机制

Tumor inhibition and immune regulation mechanism of cisplatin combined with ginsenoside Rh2 on 4T1 breast cancer tumor-bearing mice

扫码查看
目的 探讨顺铂联合人参皂苷Rh2对4T1乳腺癌荷瘤小鼠的抑瘤及免疫调控机制.方法 建立4T1乳腺癌荷瘤小鼠,分为模型组、Rh2组、顺铂组和联合用药组(顺铂+Rh2).记录小鼠一般状态,观察肿瘤组织的病理结构,采用免疫组化法检测炎性因子IL-2、IL-10、IFN-γ和多药耐药蛋白P-糖蛋白(P-glycoprotein,Pgp)的表达水平,评价联合用药的抑瘤效果和免疫调节机制.结果 模型组、Rh2组和联合用药组小鼠生活状态较好,顺铂组小鼠精神状态萎靡、运动能力下降、毛发枯槁脱落、食欲减退及腹泻.与模型组比较,各给药组小鼠的体重均降低、肿瘤体积均减小及肿瘤坏死面积均增大,肿瘤组织中IL-2、IFN-γ蛋白水平均明显增高,IL-10蛋白水平均明显降低,组间差异显著均有统计学意义(P<0.05);PgP蛋白水平在顺铂组明显增高,差异显著有统计学意义(P<0.05),其他各组间未见明显差异(P>0.05).结论 联合用药能够通过增强机体免疫功能及对抗肿瘤组织对顺铂的多药耐药性,从而加强治疗效果,该联合疗法具有重要的临床应用价值,为从中药中发现联合免疫治疗药物提供新的思路.
Objective To investigate the tumor suppression and immune regulation mechanism of cisplatin and gin-senoside Rh 2 in 4T1 breast cancer tumor-bearing mice.Methods 4T1 breast cancer was divided into model group,Rh 2 group and cisplatin group,combination group(cisplatin+Rh 2).The general status of mice was recorded,the patho-logical structure of tumor tissue was observed,the protein expression levels of inflammatory factors IL-2,IL-2,IL-10,IFN-γ and multi-drug resistance protein Pgp were detected by immunohistochemistry,and the tumor suppressive effect and immune regulation mechanism of the combination were evaluated.Results The mice in the model group,Rh 2 group and the combination group had good living condition,while the cisplatin group had depressed mental state,de-creased exercise ability,withered hair,decreased appetite and diarrhea.Compared with the model group,the mice had decreased body weight,tumor volume,tumor necrosis area,IL-2 and IFN-γ protein levels,IL-10 protein levels were significantly lower(P<0.05);P gP protein levels were significantly higher in cisplatin group(P<0.05),and no signifi-cant differences among other groups(P>0.05).Conclusion Combination therapy can strengthen the therapeutic effect by enhancing the immune function and the multi-drug resistance to cisplatin.This combination therapy has important clinical application value and provides new ideas for the discovery of combined immunotherapy drugs from traditional Chinese medicine.

CisplatinGinsenoside RH2Breast cancerTumor suppressionImmune regulation

刘国莹、胡斌、黄可欣、李树蕾、朱亦宸、王家辉、张可欣、张津铭

展开 >

吉林大学第一医院

吉林大学2021级白求恩第三临床医学院

吉林大学基础医学院,吉林长春 130021

顺铂 人参皂苷Rh2 乳腺癌 抑瘤 免疫调控

2024

中国实验诊断学
吉林大学中日联谊医院 上海交通大学医学院附属瑞金医院

中国实验诊断学

CSTPCD
影响因子:1.273
ISSN:1007-4287
年,卷(期):2024.28(12)